Clinical Trial Update: Phase III Clinical Trial Evaluating the Resection Efficacy of 5-Aminolevulinic Acid Hydrochloride (5-ALA HCl) Fluorescence-Guided Microsurgery Versus Conventional White Light Microsurgery in Patients With Malignant Glioma (WHO Grade 3/4) [Phase 3]

View source ↗

Summary

A Phase III clinical trial is evaluating resection efficacy using fluorescence-guided surgery with 5-ALA HCl versus conventional white-light microsurgery in mal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Glioma

Drugs mentioned

• 5-ALA HCl (5-aminolevulinic acid hydrochloride) (5-aminolevulinic acid hydrochloride)

Snippet

Sponsor: Lee's Pharmaceutical Limited | Conditions: 5-aminolevulinic Acid, Fluorescence-guided Resection | Phase 3 | Status: RECRUITING